These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 19578817)
1. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients. Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Niederau C; Backmerhoff F; Schumacher B; Niederau C Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126 [TBL] [Abstract][Full Text] [Related]
3. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Koss K; Satsangi J; Fanning GC; Welsh KI; Jewell DP Genes Immun; 2000 Feb; 1(3):185-90. PubMed ID: 11196710 [TBL] [Abstract][Full Text] [Related]
4. Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection. Campos N; Magro F; Castro AR; Cabral J; Rodrigues P; Silva R; Appelberg R; Rodrigues S; Lopes S; Macedo G; Sarmento A Immunobiology; 2011 Aug; 216(8):961-70. PubMed ID: 21269730 [TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience. Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662 [TBL] [Abstract][Full Text] [Related]
6. The circulating common gamma chain (CD132) in inflammatory bowel disease. Nielsen OH; Kirman I; Johnson K; Giedlin M; Ciardelli T Am J Gastroenterol; 1998 Mar; 93(3):323-8. PubMed ID: 9517632 [TBL] [Abstract][Full Text] [Related]
7. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis. Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319 [TBL] [Abstract][Full Text] [Related]
8. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866 [TBL] [Abstract][Full Text] [Related]
9. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452 [TBL] [Abstract][Full Text] [Related]
10. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396 [TBL] [Abstract][Full Text] [Related]
11. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Celik Y; Dagli U; Kiliç MY; Törüner M; Ozen SC; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM Scand J Gastroenterol; 2006 May; 41(5):559-65. PubMed ID: 16638698 [TBL] [Abstract][Full Text] [Related]
12. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis. Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923 [TBL] [Abstract][Full Text] [Related]
13. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
14. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144 [TBL] [Abstract][Full Text] [Related]
15. Profile of soluble cytokine receptors in Crohn's disease. Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533 [TBL] [Abstract][Full Text] [Related]
16. Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease. Ludwiczek O; Kaser A; Novick D; Dinarello CA; Rubinstein M; Tilg H Eur Cytokine Netw; 2005; 16(1):27-33. PubMed ID: 15809203 [TBL] [Abstract][Full Text] [Related]
17. [Levels of cytokines in mucosal biopsies of Crohn's colitis. Physiopatological observations]. Marongiu L; Scintu F; Melis MV; Pisano M; Zorcolo L; Capra F; Casula G Minerva Chir; 2002 Feb; 57(1):35-40. PubMed ID: 11832856 [TBL] [Abstract][Full Text] [Related]
18. Significance of inflammatory cytokines in the progression of colorectal cancer. Chung YC; Chang YF Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431 [TBL] [Abstract][Full Text] [Related]